Page last updated: 2024-11-02

oxymetazoline and Pulmonary Hypertension

oxymetazoline has been researched along with Pulmonary Hypertension in 2 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perrin, S1
Montani, D1
O'Connell, C1
Günther, S1
Girerd, B1
Savale, L1
Guignabert, C1
Sitbon, O1
Simonneau, G1
Humbert, M1
Chaumais, MC1
Schnabel, KH1
Schulz, V1
Busch, S1
Just, H1

Other Studies

2 other studies available for oxymetazoline and Pulmonary Hypertension

ArticleYear
Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study.
    The European respiratory journal, 2015, Volume: 46, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amines; Amphetamines; Case-Control Studies; Female; Humans; Hyperten

2015
[Drug-induced primary vascular pulmonary hypertension. Contribution to its etiology and clinical course].
    Die Medizinische Welt, 1976, Jun-25, Volume: 27, Issue:26

    Topics: Adult; Aminorex; Aniline Compounds; Appetite Depressants; Female; Humans; Hypertension, Pulmonary; I

1976